English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

According to last year’s status report on the global burden of cancer, colorectal carcinoma is a rising major medical concern with an estimated rate of over 1.8 million new patients and 881,000 cessations annually, making it the second main cause of cancer-related mortality worldwide (1). Of all colorectal cancer patients, 40–76% will develop colorectal liver metastases (CRLM) in the course of their disease (2-4).

The rapidly expanding role of thermal ablation in the treatment of colorectal liver metastases